Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar abltech (< 20) Submitted: 6/22/2011 2:53:26 PM : Outperform Start Price: $1.59 ALXA Score: -79.54

Great pipeline, well funded.

Featured Broker Partners


Advertisement